Ana Petrovic is the director of investments and chief operating officer at Pilatus Capital. Prior to joining Pilatus Capital, Ana was a vice president on the life sciences deal team at Hercules Capital, a venture debt firm. She joined Hercules Capital from Fluidigm Corporation, a life science tools company, where she was the director of corporate development and investor relations. Before joining Fluidigm Corporation, she worked in investor relations strategy at Westwicke Partners, a strategic communications and capital markets advisory firm. Prior to Westwicke Partners, Ana worked on Wall Street in sell-side equity research, most recently at Lazard Capital Markets, covering biotech equities. Earlier in her career, Ana was a molecular biologist involved in HIV research at the National Institutes of Allergy and Infectious Diseases. She has co-authored several articles published in scientific journals, including the Journal of Biomedical Medicine and the Journal of Virology.
Ana holds an MBA in finance and marketing from the University of Chicago, Booth School of Business, an MS in biochemistry from George Washington University, and a BS in microbiology from the University of Maryland.